Similar to the effect of CCL20 on HSC, CCL20 also promoted NF‐κB activation and up‐regulated ALKBH5 expression in a dose‐dependent manner in IR‐HCC cells (Figure S9F). This evidence concerns the gene CCL20 and hepatocellular carcinoma.